S&P 500 7,698.92 +0.29%
Nasdaq 26,345.25 +0.67%
S&P/TSX 35,945.11 +0.00%
Apple 345.64 +0.50%
Nvidia 217.23 +0.57%
Microsoft 531.59 −0.19%
Shopify 231.34 −1.95%
Royal Bank 283.27 −0.35%
CAD/USD 0.7127 −0.13%
LIVE · 10:35 ET
Market ClerkRecap
Tue Oct 27 · markets open3 signals today140 insider buys this week · $73.9MCIRO short report next: Oct 31The week ahead

ENGN

enGene Therapeutics Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
1.59
+0.00 +0.32%
USD · close Oct 27

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

One year, everything drawn on

252 SESSIONS · DAILY CLOSES
138.884.730.58Sep 22 · Interim Chief Medical Officer buy $10KSep 8 · 10-Q filed (Q3 2026)Sep 8 · 10-Q filed (Q2 2026)Sep 8 · 10-Q filed (Q1 2026)Dec 22 · 10-K filed (FY 2025)Dec 22 · 10-K filed (Q4 2025)Sep 8 · 10-Q filed (Q3 2025)Sep 8 · 10-Q filed (Q2 2025)Sep 8 · 10-Q filed (Q1 2025)Dec 22 · 10-K filed (FY 2024)Dec 22 · 10-K filed (Q4 2024)OCT 2025JAN 2026APRJULOCT
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-10-27
Insiders (90d): $10K net buying · 1 distinct buyer
Shorts (latest report): 1.2M short · −270K last period
Every line of the math
78PASS

Congress is trading it

No STOCK Act disclosure names ENGN.

Insider activity

ALL 1
DateInsiderTypeValue
Sep 22Interim Chief Medical OfficerBuy$10K
Watch ENGN. Know when insiders buy.
One email the day a filing lands. Free.